Status | Study |
Enrolling by invitation |
Study Name: Comparative Autoantibody and Immunologic Cell Marker Study Condition: Autoimmune Diseases Lupus Erythematosus, Systemic Communic Date: 2015-04-17 |
Recruiting |
Study Name: Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT Condition: Primary Immunodeficiency Syndromes Congenital Bone Marrow Failure Syndromes Date: 2013-10-10 Interventions: Drug: Hydroxyurea Hydroxyurea |
Recruiting |
Study Name: Immune Disorder HSCT Protocol Condition: Immune Deficiency Disorders Severe Combined Immunodeficiency Date: 2013-03-19 Interventions: Drug: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan Between days - |
Withdrawn |
Study Name: Fluorodeoxyglucose Imaging Studies to Detect Lymphoma Condition: Autoimmune Lymphoproliferative Syndrome Lymphoma Date: 2012-08-23 |
Completed |
Study Name: Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS) Condition: ALPS Hypersplenism Lymphadenopathy Date: 2008-01-15 Interventions: Drug: Valproic Acid Oral admin |
Active, not recruiting |
Study Name: Sirolimus for Autoimmune Disease of Blood Cells Condition: Autoimmune Pancytopenia Autoimmune Lymphoproliferative Syndrome Date: 2006-10-24 Interventions: Drug: sirolimus Tablet or liquid; taken once or twice daily; dosage is based on establishing a serum tro |
Completed |
Study Name: Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma Condition: Lymphoproliferative Disorders Lymphoma Date: 2003-09-09 |
Completed |
Study Name: Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome Condition: Autoimmune Disease Lymphatic Disease Lymphoproliferative D Date: 2003-07-21 Interventions: Drug: Pyrimethamine |
Completed |
Study Name: Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome Condition: Autoimmune Disease Lymphoproliferative Disorder Date: 2001-03-28 Interventions: Drug: Fansidar (pyrimethamine and sulfadoxine) |
Recruiting |
Study Name: Study of Autoimmune Lymphoproliferative Syndrome (ALPS) Condition: Autoimmune Lymphproliferative Syndrome Date: 1999-11-03 |